Neuron Specific Enolase (NSE) as Outcome Parameter of Cooling Therapy After Survived Sudden Cardiac Death

University of Leipzig

Status: Completed

Conditions: Hypothermia; Cardiac Arrest

Treatments: Device: Coolgard; Device: ArcticSun

Study type: Observational

Funder types: Other

Identifiers

NCT01102153

COOL-NSE

Details and patient eligibility

About

Sudden cardiac death remains one of the major leading causes of death. Therapeutic hypothermia is a validated standard procedure to avoid or minimize cognitive deficits after cardiac arrest. To assess the efficiency of different cooling methods and further improve these methods, the investigators collected blood samples to measure the neuron specific enolase (NSE) in patients treated with invasive cooling as compared to patients treated with non-invasive cooling.

Full description

Consecutive patients with restoration of spontaneous circulation after resuscitation due to sudden cardiac death were randomized to either non-invasive or invasive cooling for at least 24 hours. NSE was collected at designated time points and compared between patients treated with invasive cooling and those treated with non-invasive cooling. Neurological outcome was assessed between groups at hospital discharge and 6 months after discharge.

Enrollment: 108 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ROSC after sudden cardiac death (SCA) due to VF/VT or PEA/Asystolia
• GCS 3

Exclusion criteria

• Non-cardiac sudden death
• Pregnancy
• Unstable circulation with high-dose inotropics
• Life-expectancy reducing concomitant illness

Trial design

108 participants in 2 patient groups

Coolgard

Description:

invasive cooling

Treatment:

Device: Coolgard

ArcticSun

Description:

non-invasive (surface) cooling

Treatment:

Device: ArcticSun